{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:36:20Z","timestamp":1789810580095,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004167","name":"Medicines for Malaria Venture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004167","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["083481"],"award-info":[{"award-number":["083481"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12936-017-2085-4","type":"journal-article","created":{"date-parts":[[2017,11,7]],"date-time":"2017-11-07T07:19:43Z","timestamp":1510039183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Screening a protein kinase inhibitor library against Plasmodium falciparum"],"prefix":"10.1186","volume":"16","author":[{"given":"Irene","family":"Hallyburton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Grimaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Woodland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Baraga\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Luksch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Spinks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Waterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5134-0329","authenticated-orcid":false,"given":"Alan H.","family":"Fairlamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0397-245X","authenticated-orcid":false,"given":"Paul G.","family":"Wyatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5238-1314","authenticated-orcid":false,"given":"Ian H.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Frearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,7]]},"reference":[{"key":"2085_CR1","doi-asserted-by":"crossref","first-page":"e16092","DOI":"10.1038\/nmicrobiol.2016.92","volume":"1","author":"AH Fairlamb","year":"2016","unstructured":"Fairlamb AH, Gow NAR, Matthews KR, Waters AP. Drug resistance in eukaryotic microorganisms. Nat Microbiol. 2016;1:e16092.","journal-title":"Nat Microbiol"},{"key":"2085_CR2","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm.4381","volume":"23","author":"B Blasco","year":"2017","unstructured":"Blasco B, Leroy D, Fidock DA. Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic. Nat Med. 2017;23:917\u201328.","journal-title":"Nat Med"},{"key":"2085_CR3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2174\/187152610791163381","volume":"10","author":"D Jirage","year":"2010","unstructured":"Jirage D, Keenan SM, Waters NC. Exploring novel targets for antimalarial drug discovery: plasmodial protein kinases. Infect Disord Drug Targets. 2010;10:134\u201346.","journal-title":"Infect Disord Drug Targets"},{"key":"2085_CR4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm.3073","volume":"19","author":"LH Miller","year":"2013","unstructured":"Miller LH, Ackerman HC, Su XZ, Wellems TE. Malaria biology and disease pathogenesis: insights for new treatments. Nat Med. 2013;19:156\u201367.","journal-title":"Nat Med"},{"key":"2085_CR5","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/prot.20278","volume":"58","author":"Anamika","year":"2005","unstructured":"Anamika, Srinivasan N, Krupa A. A genomic perspective of protein kinases in Plasmodium falciparum. Proteins. 2005;58:180\u20139.","journal-title":"Proteins"},{"key":"2085_CR6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2164-5-79","volume":"5","author":"P Ward","year":"2004","unstructured":"Ward P, Equinet L, Packer J, Doerig C. Protein kinases of the human malaria parasite Plasmodium falciparum: the kinome of a divergent eukaryote. BMC Genomics. 2004;5:79.","journal-title":"BMC Genomics"},{"key":"2085_CR7","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.4155\/fmc.12.183","volume":"4","author":"IS Lucet","year":"2012","unstructured":"Lucet IS, Tobin A, Drewry D, Wilks AF, Doerig C. Plasmodium kinases as targets for new-generation antimalarials. Future Med Chem. 2012;4:2295\u2013310.","journal-title":"Future Med Chem"},{"key":"2085_CR8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bbapap.2003.11.021","volume":"1697","author":"C Doerig","year":"2004","unstructured":"Doerig C. Protein kinases as targets for anti-parasitic chemotherapy. BBA-Proteins Proteomics. 2004;1697:155\u201368.","journal-title":"BBA-Proteins Proteomics"},{"key":"2085_CR9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature12782","volume":"504","author":"CW McNamara","year":"2013","unstructured":"McNamara CW, Lee MC, Lim CS, Lim SH, Roland J, Nagle A, et al. Targeting Plasmodium PI(4)K to eliminate malaria. Nature. 2013;504:248\u201353.","journal-title":"Nature"},{"key":"2085_CR10","doi-asserted-by":"crossref","first-page":"eaad9735","DOI":"10.1126\/scitranslmed.aad9735","volume":"9","author":"T Paquet","year":"2017","unstructured":"Paquet T, Le Manach C, Cabrera DG, Younis Y, Henrich PP, Abraham TS, et al. Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase. Sci Transl Med. 2017;9:eaad9735.","journal-title":"Sci Transl Med"},{"key":"2085_CR11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/ncomms1558","volume":"2","author":"L Solyakov","year":"2011","unstructured":"Solyakov L, Halbert J, Alam MM, Semblat JP, Dorin-Semblat D, Reininger L, et al. Global kinomic and phospho-proteomic analyses of the human malaria parasite Plasmodium falciparum. Nat Commun. 2011;2:565.","journal-title":"Nat Commun"},{"key":"2085_CR12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cmdc.200700139","volume":"3","author":"R Brenk","year":"2008","unstructured":"Brenk R, Schipani A, James D, Krasowski A, Gilbert IH, Frearson J, et al. Lessons learnt from assembling screening libraries for drug discovery for neglected diseases. Chem Med Chem. 2008;3:435\u201344.","journal-title":"Chem Med Chem"},{"key":"2085_CR13","unstructured":"The Prestwick Library. \n                        http:\/\/www.prestwickchemical.com\/index.php?pa=26\n                        \n                    ."},{"key":"2085_CR14","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1128\/AAC.48.5.1807-1810.2004","volume":"48","author":"TN Bennett","year":"2004","unstructured":"Bennett TN, Paguio M, Gligorijevic B, Seudieu C, Kosar AD, Davidson E, et al. Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy. Antimicrob Agents Chemother. 2004;48:1807\u201310.","journal-title":"Antimicrob Agents Chemother"},{"key":"2085_CR15","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/227168a0","volume":"227","author":"JP Jacobs","year":"1970","unstructured":"Jacobs JP, Jones CM, Baille JP. Characteristics of a human diploid cell designated MRC-5. Nature. 1970;227:168\u201370.","journal-title":"Nature"},{"key":"2085_CR16","doi-asserted-by":"crossref","first-page":"9059","DOI":"10.1073\/pnas.0802982105","volume":"105","author":"D Plouffe","year":"2008","unstructured":"Plouffe D, Brinker A, McNamara C, Henson K, Kato N, Kuhen K, et al. In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. Proc Natl Acad Sci USA. 2008;105:9059\u201364.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2085_CR17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0014-4894(83)90007-3","volume":"55","author":"JD Chulay","year":"1983","unstructured":"Chulay JD, Haynes JD, Diggs CL. Plasmodium falciparum: assessment of in vitro growth by [3H]hypoxanthine incorporation. Exp Parasitol. 1983;55:138\u201346.","journal-title":"Exp Parasitol"},{"key":"2085_CR18","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/cmdc.201100278","volume":"6","author":"VC Smith","year":"2011","unstructured":"Smith VC, Cleghorn LA, Woodland A, Spinks D, Hallyburton I, Collie IT, et al. Optimisation of the anti-Trypanosoma brucei activity of the opioid agonist U50488. Chem Med Chem. 2011;6:1832\u201340.","journal-title":"Chem Med Chem"},{"key":"2085_CR19","unstructured":"Activity Base. \n                        http:\/\/www.idbs.com\/\n                        \n                    ."},{"key":"2085_CR20","unstructured":"International Centre for Kinase Profiling, University of Dundee. \n                        http:\/\/www.kinase-screen.mrc.ac.uk\/\n                        \n                    ."},{"key":"2085_CR21","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1126\/science.1075762","volume":"298","author":"G Manning","year":"2002","unstructured":"Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science. 2002;298:1912\u201334.","journal-title":"Science"},{"key":"2085_CR22","doi-asserted-by":"crossref","first-page":"e1001169","DOI":"10.1371\/journal.pmed.1001169","volume":"9","author":"M Delves","year":"2012","unstructured":"Delves M, Plouffe D, Scheurer C, Meister S, Wittlin S, Winzeler E, Sinden RE, Leroy D. The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites. PLoS Med. 2012;9:e1001169.","journal-title":"PLoS Med"},{"key":"2085_CR23","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1021\/acs.jmedchem.6b00028","volume":"59","author":"NR Norcross","year":"2016","unstructured":"Norcross NR, Baragana B, Wilson C, Hallyburton I, Osuna-Cabello M, Norval S, et al. Trisubstituted pyrimidines as efficacious and fast-acting antimalarials. J Med Chem. 2016;59:6101\u201320.","journal-title":"J Med Chem"},{"key":"2085_CR24","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature14451","volume":"522","author":"B Baragana","year":"2015","unstructured":"Baragana B, Hallyburton I, Lee MC, Norcross NR, Grimaldi R, Otto TD, et al. A novel multiple-stage antimalarial agent that inhibits protein synthesis. Nature. 2015;522:315\u201320.","journal-title":"Nature"},{"key":"2085_CR25","doi-asserted-by":"crossref","first-page":"9672","DOI":"10.1021\/acs.jmedchem.6b00723","volume":"59","author":"B Baragana","year":"2016","unstructured":"Baragana B, Norcross NR, Wilson C, Porzelle A, Hallyburton I, Grimaldi R, et al. Discovery of a quinoline-4-carboxamide derivative with a novel mechanism of action, multistage antimalarial activity, and potent in vivo efficacy. J Med Chem. 2016;59:9672\u201385.","journal-title":"J Med Chem"},{"key":"2085_CR26","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1021\/jm100112j","volume":"53","author":"C Bissantz","year":"2010","unstructured":"Bissantz C, Kuhn B, Stahl M. A medicinal chemist\u2019s guide to molecular interactions. J Med Chem. 2010;53:5061\u201384.","journal-title":"J Med Chem"},{"key":"2085_CR27","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.bmcl.2015.04.005","volume":"25","author":"H Zhao","year":"2015","unstructured":"Zhao H, Caflisch A. Current kinase inhibitors cover a tiny fraction of fragment space. Bioorg Med Chem Lett. 2015;25:2372\u20136.","journal-title":"Bioorg Med Chem Lett"},{"key":"2085_CR28","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nrd2445","volume":"6","author":"PD Leeson","year":"2007","unstructured":"Leeson PD, Springthorpe B. The influence of drug-like concepts on decision-making in medicinal chemistry. Nat Rev Drug Discov. 2007;6:881\u201390.","journal-title":"Nat Rev Drug Discov"},{"key":"2085_CR29","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.drudis.2011.06.001","volume":"16","author":"RJ Young","year":"2011","unstructured":"Young RJ, Green DV, Luscombe CN, Hill AP. Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity. Drug Discov Today. 2011;16:822\u201330.","journal-title":"Drug Discov Today"},{"key":"2085_CR30","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.drudis.2009.07.014","volume":"14","author":"TJ Ritchie","year":"2009","unstructured":"Ritchie TJ, MacDonald SJF. The impact of aromatic ring count on compound developability\u2014are too many aromatic rings a liability in drug design? Drug Discov Today. 2009;14:1011\u201320.","journal-title":"Drug Discov Today"},{"key":"2085_CR31","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drudis.2010.11.014","volume":"16","author":"TJ Ritchie","year":"2011","unstructured":"Ritchie TJ, MacDonald SJF, Young RJ, Pickett SD. The impact of aromatic ring count on compound developability: further insights by examiing carbo- and hetero-aromatic and -aliphatic ring types. Drug Discov Today. 2011;16:164\u201371.","journal-title":"Drug Discov Today"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-017-2085-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,7]],"date-time":"2017-11-07T07:19:58Z","timestamp":1510039198000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-017-2085-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2085"],"URL":"https:\/\/doi.org\/10.1186\/s12936-017-2085-4","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,7]]},"article-number":"446"}}